A rating of 53 puts Ultragenyx Pharmaceutical Inc (RARE) near the middle of the Biotechnology industry according to InvestorsObserver. Ultragenyx Pharmaceutical Inc's score of 53 means it scores higher than 53% of stocks in the industry. Ultragenyx Pharmaceutical Inc also received an overall rating of 38, putting it above 38% of all stocks. Biotechnology is ranked 109 out of the 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Ultragenyx Pharmaceutical Inc Stock Today?
Ultragenyx Pharmaceutical Inc (RARE) stock has gained 1.54% while the S&P 500 is down -0.25% as of 11:47 AM on Monday, Jun 14. RARE has gained $1.57 from the previous closing price of $101.71 on volume of 209,095 shares. Over the past year the S&P 500 is higher by 38.16% while RARE has gained 49.23%. RARE lost -$3.12 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Ultragenyx Pharmaceutical Inc (RARE) Stock.
